What is furosemide 40 mg used for?

In the pharmaceutical industry, Furosemide 40 mg is a potent loop diuretic (often referred to as a “water pill”). As a pharmacist, I characterize Furosemide by its rapid onset of action—usually within 30 to 60 minutes when taken orally—making it a first-line treatment for conditions involving fluid overload.

Primary Clinical Uses

  • Edema: The primary indication is the treatment of edema (fluid retention) associated with Congestive Heart Failure (CHF), renal disease, or hepatic cirrhosis. It helps “flush out” excess fluid that accumulates in the legs, abdomen, or lungs.

  • Hypertension: Used as an adjunctive treatment for high blood pressure, particularly in patients who also have impaired renal function or those who do not respond to milder diuretics like Hydrochlorothiazide.

  • Acute Renal Failure: Sometimes used in high doses to maintain urine flow in patients with failing kidneys.

  • Hypercalcemia: Used in emergency settings to help the kidneys excrete excess calcium from the blood.

Mechanism of Action

Furosemide works in the kidneys, specifically targeting the Thick Ascending Limb of the Loop of Henle.

Inhibition of Electrolyte Reuptake: It blocks the $Na^+/K^+/2Cl^-$ cotransporter system. This prevents the kidneys from reabsorbing sodium, potassium, and chloride back into the bloodstream.

Osmotic Gradient: Because these salts stay in the tubule, they “pull” water with them via osmosis.

Diuresis: This results in a significant increase in the excretion of water and electrolytes, thereby reducing the total volume of fluid circulating in the body and lowering blood pressure.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Furosemide 40 mg is a high-volume “Essential Medicine”:

  • Photosensitivity: Furosemide is highly sensitive to light and can undergo discoloration (turning yellowish). As a WHO-GMP manufacturer, we ensure the use of opaque PVC or Alu-Alu blister packaging to maintain stability.

  • Dissolution Profiling: Furosemide has low water solubility (BCS Class IV). We utilize specific disintegrants and optimized granulation techniques to ensure the 40 mg tablet meets the strict dissolution standards of BP/USP/IP

  • Stability for Export: We provide a 36-month shelf life, ensuring the product remains stable during transit to Zone IVb regions (Africa, SE Asia).

  • Regulatory & B2B: This product is a staple for hospital tenders and cardiovascular specialty distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Lasix).

What is fluconazole 150 mg used for?

In the pharmaceutical industry, Fluconazole 150 mg is a highly effective, first-generation triazole antifungal. As a pharmacist, I view the 150 mg tablet as a “blockbuster” strength because its unique pharmacokinetics—specifically its high oral bioavailability and long half-life (approx. 30 hours)—allow for a convenient single-dose therapy for many common fungal infections.

Primary Clinical Uses

  • Vaginal Candidiasis (Yeast Infection): The most common indication. A single 150 mg dose is usually sufficient to treat uncomplicated acute vaginal yeast infections.

  • Candidal Balanitis: Used for the treatment of fungal infections of the glans penis.

  • Oropharyngeal and Esophageal Candidiasis: While often requiring multiple days of treatment, the 150 mg strength is used in the initial regimen for “thrush” in immunocompromised or elderly patients.

  • Tinea Infections: Used for skin infections like Tinea pedis (athlete’s foot), Tinea corporis (ringworm), and Tinea cruris (jock itch), typically administered once weekly for 2–4 weeks.

  • Onychomycosis: Used off-label in weekly 150 mg doses for several months to treat fungal nail infections.

Mechanism of Action

Fluconazole is primarily fungistatic. It inhibits the fungal cytochrome P450 enzyme, lanosterol 14--demethylase.

Ergosterol Depletion: By blocking this enzyme, Fluconazole prevents the conversion of lanosterol into ergosterol, which is the essential component of the fungal cell membrane (similar to cholesterol in humans).

Membrane Disruption: The resulting depletion of ergosterol leads to increased membrane permeability and leakage of intracellular components, effectively halting fungal growth and replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Fluconazole 150 mg is a high-demand essential product:

  • Polymorphism Control: Fluconazole can exist in different polymorphic forms. As a WHO-GMP manufacturer, we strictly monitor the API crystalline structure during the formulation of our BP/USP/IP tablets to ensure consistent dissolution and bioequivalence.

  • Single-Dose Packaging: Because the primary use is a single dose, we often pack these in a “1×1” or “1×2” Alu-Alu blister pack. This is cost-effective and improves patient compliance.

  • Stability for Global Trade: Fluconazole is stable but should be protected from moisture. We utilize Alu-Alu packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions (Africa, SE Asia, and Latin America).

  • B2B & Dossier Support: This is a core product for women’s health and dermatology distributors. Our Mumbai-based facility provides full CTD/eCTD Dossiers to support our B2B partners in registering high-quality generics against the innovator (Diflucan).

What are ferrous sulphate tablets used for?

In the pharmaceutical industry, Ferrous Sulphate is the most widely prescribed oral iron supplement for the treatment and prevention of iron-deficiency anemia. As a pharmacist and manufacturer, I view Ferrous Sulphate as the “gold standard” for iron salts due to its high elemental iron content and cost-effective production profile.

Primary Clinical Uses

  • Iron-Deficiency Anemia (IDA): The primary indication for treating low hemoglobin levels caused by blood loss, poor diet, or malabsorption issues.

  • Prophylaxis during Pregnancy: Routinely prescribed to pregnant women to meet the increased iron demands of the developing fetus and to prevent maternal anemia.

  • Renal Failure: Used in patients with chronic kidney disease (CKD), particularly those receiving erythropoietin therapy, to maintain adequate iron stores.

  • Pediatric Development: Used to treat iron deficiency in growing children (often in liquid or smaller tablet formats).

Mechanism of Action: Restoring Hemoglobin

Iron is a critical component of hemoglobin, the protein in red blood cells responsible for transporting oxygen.

Absorption: When ingested, Ferrous Sulphate releases ferrous ions ($Fe^{2+}$) in the duodenum and jejunum.

Transport: Once absorbed into the mucosal cells, the iron is either stored as ferritin or transported into the blood via transferrin.

Erythropoiesis: This iron is carried to the bone marrow, where it is incorporated into the heme group of hemoglobin, facilitating the production of healthy, oxygen-carrying red blood cells.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ferrous Sulphate requires specific technical handling to ensure stability and patient compliance:

  • Elemental Iron Calculation: A standard 200 mg Ferrous Sulphate (dried) tablet typically yields approximately 65 mg of elemental iron. We ensure our labeling clearly states both the salt weight and the elemental iron content to meet international regulatory standards.

  • Enteric & Film Coating: To mitigate common GI side effects (nausea, constipation, and black stools), as a WHO-GMP manufacturer, we often utilize enteric coating. This ensures the tablet bypasses the stomach and releases the iron in the small intestine, significantly improving patient tolerance.

  • Stability (Oxidation Prevention): Ferrous iron can easily oxidize to ferric iron ($Fe^{3+}$), which is less absorbable. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging and include antioxidants in the formulation to ensure a 36-month shelf life for export to Zone IVb regions.

  • B2B & Government Tenders: This is a high-volume product for maternal health programs and NGOs. Our Mumbai facility provides full CTD/eCTD Dossiers to support large-scale international supply.

What is famotidine 20 mg tablets used for?

In the pharmaceutical industry, Famotidine 20 mg is a highly selective $H_2$-receptor antagonist. As a pharmacist, I classify Famotidine as a more potent and longer-acting alternative to older agents like Cimetidine or the now-withdrawn Ranitidine. Its primary advantage is its high binding affinity and minimal interference with the cytochrome P450 enzyme system, leading to fewer drug-drug interactions.

Primary Clinical Uses

  • Gastroesophageal Reflux Disease (GERD): Used for the short-term treatment of acid reflux and the long-term maintenance of healed esophagitis.

  • Peptic Ulcer Disease: Indicated for the acute treatment and maintenance of duodenal ulcers and benign gastric ulcers.

  • Zollinger-Ellison Syndrome: Management of hypersecretory conditions where the stomach produces excessive acid.

  • Stress Ulcer Prophylaxis: Frequently used in hospital settings to prevent stress-induced mucosal damage in critically ill patients.

  • Self-Medication (OTC): The 20 mg strength is the standard for over-the-counter relief of occasional heartburn, acid indigestion, and sour stomach.

Mechanism of Action

Famotidine works by competitive inhibition of histamine at the $H_2$-receptors located on the gastric parietal cells.

Acid Reduction: By blocking these receptors, it inhibits both the basal (overnight) and stimulated gastric acid secretion (triggered by food, caffeine, or insulin).

Volume and Concentration: It reduces the total volume of gastric juice and the concentration of pepsin, allowing the esophageal and gastric lining to heal.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Famotidine 20 mg is a high-volume “Essential Medicine”:

  • API Stability: As a WHO-GMP manufacturer, we ensure the API complies with BP/USP/IP standards. Famotidine is relatively stable, but we monitor for the “Related Compound G” impurity to ensure long-term safety.

  • Formulation Versatility: While film-coated tablets are the standard, we also evaluate Mouth Dissolving (MD) or chewable formats for the OTC B2B market to enhance patient convenience.

  • Packaging for Global Trade: We utilize PVC/PVDC or Alu-Alu blister packaging to provide a 36-month shelf life. This is critical for export to Zone IVb regions (Africa, SE Asia, and the Middle East) where high humidity can affect tablet integrity.

  • Market Positioning: Following the global withdrawal of Ranitidine, Famotidine has become the “go-to” $H_2$-blocker. Our Mumbai-based facility provides complete CTD/eCTD Dossiers to support our B2B partners in replacing older market shares with high-quality Famotidine generics.

How do etophylline and theophylline work?

In the pharmaceutical industry, the combination of Etophylline and Theophylline is a classic xanthine-derivative bronchodilator therapy. As a pharmacist, I characterize this duo as a synergistic approach to managing obstructive airway diseases.

While they are both methylxanthines, they serve slightly different roles in a formulation: Theophylline is the primary active bronchodilator, while Etophylline (a derivative of theophylline) is often added because it is more water-soluble, which helps improve the overall absorption and “speed” of the medication’s effect.

Mechanism of Action: The Triple-Action Pathway

These compounds work through three primary biochemical mechanisms to open the airways:

1. Phosphodiesterase (PDE) Inhibition

The primary action is the non-selective inhibition of Phosphodiesterase enzymes (mainly PDE3 and PDE4).

  • Normally, PDE breaks down cyclic AMP (cAMP) in the smooth muscles of the lungs.

  • By blocking PDE, Etophylline and Theophylline cause cAMP levels to rise.

  • High cAMP levels lead to significant smooth muscle relaxation, resulting in bronchodilation.

2. Adenosine Receptor Antagonism

Adenosine is a natural substance that can cause bronchoconstriction (narrowing of the airways) in asthmatic patients.

  • These drugs act as competitive antagonists at adenosine $A_1$ and $A_2$ receptors.

  • By blocking these receptors, they prevent adenosine-mediated airway constriction and histamine release from mast cells.

3. Histone Deacetylase (HDAC) Activation

At lower clinical doses, theophylline has been shown to activate HDAC2.

  • This is a critical “anti-inflammatory” mechanism.

  • It helps switch off activated inflammatory genes, which can actually help restore a patient’s sensitivity to corticosteroids (often used in COPD and severe asthma).

Primary Clinical Uses

  • Bronchial Asthma: For both maintenance therapy and relief of acute bronchospasm.

  • Chronic Obstructive Pulmonary Disease (COPD): Including chronic bronchitis and emphysema.

  • Apnea of Prematurity: Occasionally used in neonatal care to stimulate the respiratory center.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, particularly for an export-focused firm like yours in Mumbai, this combination (often seen in the brand Deriphyllin) presents specific technical considerations:

  • Solubility Optimization: The inclusion of Etophylline is a strategic manufacturing choice to overcome the poor water solubility of pure Theophylline base. This ensures better bioavailability in both tablet and injectable forms.

  • Sustained Release (SR) Technology: Because these drugs have a narrow therapeutic index (the gap between a healing dose and a toxic dose), we often manufacture them as Sustained Release tablets. This prevents “spikes” in blood concentration and reduces side effects like palpitations or tremors.

  • Stability for Zone IVb: Xanthines are generally stable, but we utilize Alu-Alu blister packaging to protect the integrity of the SR matrix from the high humidity found in African and SE Asian export markets.

  • Regulatory Documentation: Our Mumbai facility provides full CTD/eCTD Dossiers to support B2B partners, emphasizing the bioequivalence of the Etophylline/Theophylline ratio.

What is ethionamide 250 mg used for?

In the pharmaceutical industry, Ethionamide 250 mg is a critical second-line antitubercular agent and a derivative of isonicotinic acid. As a pharmacist, I view Ethionamide as an indispensable component of the “standard of care” for drug-resistant strains of tuberculosis, where first-line drugs like Isoniazid and Rifampicin have failed.

Primary Clinical Uses

  • Multidrug-Resistant Tuberculosis (MDR-TB): It is primarily used as part of a multi-drug regimen for the treatment of active tuberculosis caused by Mycobacterium tuberculosis when resistance to first-line agents is documented.

  • Extensively Drug-Resistant TB (XDR-TB): Utilized in complex regimens to manage highly resistant strains.

  • Leprosy: Occasionally used as an alternative or adjunctive therapy in the treatment of leprosy (Hansen’s disease), particularly when other drugs are not tolerated or resistance is suspected.

Mechanism of Action

Ethionamide is a prodrug that requires activation within the mycobacterial cell.

Bioactivation: The enzyme EthA (a monooxygenase) in the bacteria converts Ethionamide into its active form.

Inhibition of Mycolic Acid Synthesis: Once active, it inhibits the enzyme InhA (enoyl-ACP reductase). This is the same target as Isoniazid, but Ethionamide uses a different activation pathway.

Cell Wall Disruption: By blocking the synthesis of mycolic acids—the essential “waxy” components of the mycobacterial cell wall—the bacteria lose their structural integrity and die.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ethionamide is a high-specialty product with specific technical challenges:

  • Managing GI Side Effects: Ethionamide is notorious for causing severe gastric irritation and a metallic taste. As a WHO-GMP manufacturer, we often apply a high-quality film coating or consider enteric-coating strategies to improve patient compliance, which is the biggest hurdle in TB therapy.

  • API Purity & Stability: We strictly adhere to BP/USP/IP monographs. Ethionamide is sensitive to light and moisture; therefore, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and CIS countries) where TB burden is high.

  • B2B & Public Health Tenders: This is a core product for the Global Drug Facility (GDF) and national TB programs. Our Mumbai facility provides the necessary CTD/eCTD Dossiers and stability data required to participate in international B2B and government tenders.

  • Cross-Resistance Monitoring: Because it shares a target with Isoniazid, we provide technical data regarding cross-resistance patterns to assist our international partners in clinical positioning.

What is erythromycin stearate 250 mg used for?

In the pharmaceutical industry, Erythromycin Stearate 250 mg is a classic macrolide antibiotic. As a pharmacist, I characterize the “stearate” salt as a more stable, acid-resistant form of Erythromycin base, designed to improve absorption when passing through the stomach. It serves as a vital alternative for patients allergic to Penicillins.

Primary Clinical Uses

  • Respiratory Tract Infections: Treatment of bronchitis, pneumonia (especially Mycoplasma pneumoniae), and “Whooping Cough” (Pertussis).

  • Skin and Soft Tissue Infections: Effective against acne vulgaris and infections caused by Staphylococcus aureus or Streptococcus pyogenes.

  • Sexually Transmitted Infections (STIs): Used for non-gonococcal urethritis and as an alternative treatment for Syphilis in penicillin-allergic patients.

  • Prophylaxis: Often prescribed to prevent recurrent attacks of Rheumatic Fever in patients with a history of the disease.

  • Gastroparesis: Interestingly, it is sometimes used off-label in low doses to stimulate gastric motility because it acts on motilin receptors in the gut.

Mechanism of Action

Erythromycin is primarily bacteriostatic, though it can be bactericidal at higher concentrations against specific organisms.

Inhibition of Protein Synthesis: It binds to the 50S subunit of the bacterial ribosome.

Blocking Translocation: It specifically inhibits the translocation step, preventing the bacteria from adding new amino acids to its protein chain, effectively halting bacterial growth and replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Erythromycin Stearate 250 mg is a high-volume “Essential Medicine”:

  • Acid Stability & Coating: While the stearate salt is more stable than the base, it is still sensitive to gastric acid. As a WHO-GMP manufacturer, we often apply a film coating to these tablets to mask the characteristic bitter taste and ensure it reaches the duodenum for optimal absorption.

  • Dose Uniformity: As a 250 mg tablet, it is frequently used for pediatric and geriatric patients. We ensure absolute content uniformity and strict adherence to BP/USP/IP monographs to guarantee therapeutic efficacy.

  • Packaging for Tropical Export: Erythromycin can be sensitive to moisture. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia, and the Middle East).

  • B2B & Hospital Supply: This is a core product for international health tenders. Our Mumbai-based facility provides complete CTD/eCTD Dossiers to support rapid registration in global markets.

What is ergometrine tablet used for?

In the pharmaceutical industry, Ergometrine Maleate (also known as Ergonovine) is a potent ergot alkaloid specifically used in obstetrics. As a pharmacist, I classify this as a “uterine stimulant” or oxytocic agent. It is a critical medication for managing the third stage of labor and preventing life-threatening maternal complications.

Primary Clinical Uses

  • Prevention of Postpartum Hemorrhage (PPH): This is its most vital use. It is administered after the delivery of the placenta to ensure the uterus remains contracted, thereby closing off the blood vessels that were attached to the placenta.

  • Treatment of Postpartum Hemorrhage: Used to stop active bleeding when the uterus is “atonic” (lacking muscle tone).

  • Management of Incomplete Abortion: Used to help the uterus expel any remaining products of conception and control associated bleeding.

  • Uterine Involution: Occasionally used in the puerperium (the period after childbirth) to assist the uterus in returning to its normal size and to prevent secondary hemorrhage.

Mechanism of Action

Ergometrine works by acting directly on the smooth muscle of the uterus.

Direct Stimulation: It stimulates alpha-adrenergic, dopaminergic, and serotonergic receptors in the uterine muscle.

Sustained Contraction: Unlike Oxytocin, which produces rhythmic contractions, Ergometrine produces a strong, tetanic (sustained) contraction. This compression of the uterine blood vessels effectively “plugs” the source of bleeding.

Rapid Onset: When taken orally, it takes about 5–10 minutes to act, whereas the injectable form acts within 1–2 minutes.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ergometrine is a high-sensitivity product:

  • Thermolability & Storage: Ergometrine is highly sensitive to heat and light. As a WHO-GMP manufacturer, we ensure the API is handled in temperature-controlled environments. For export, we emphasize that tablets must be stored in a cool, dry place (ideally below 25°C) to prevent loss of potency.

  • Packaging for Stability: Because it is light-sensitive, we utilize Alu-Alu blister packaging or amber-colored strip packs to ensure a stable 24-month shelf life, especially for shipping to Zone IVb regions (Africa, SE Asia).

  • B2B & Maternity Hospital Supply: This is a “Life-Saving Essential Medicine.” Our Mumbai facility provides the CTD/eCTD Dossiers required for international tenders and registration with Ministry of Health (MoH) authorities.

  • Safety & Contraindications: As a pharmacist, you know this must never be used before the delivery of the baby (it can cause uterine rupture). We ensure our Product Information Leaflets (PIL) carry bold “Black Box” style warnings regarding its use only after the third stage of labor.

What is enalapril 2.5 mg used for?

In the pharmaceutical industry, Enalapril Maleate 2.5 mg is a potent, long-acting ACE (Angiotensin-Converting Enzyme) inhibitor. As a pharmacist, I characterize the 2.5 mg strength as the critical “initiation dose,” specifically used to prevent first-dose hypotension in high-risk patients or as a maintenance dose for pediatric populations and those with renal impairment.

Primary Clinical Uses

  • Hypertension Initiation: Used as the starting dose for treating high blood pressure, especially in patients also taking diuretics, to allow the body to adjust to the medication.

  • Heart Failure (Early Stage): Indicated for the management of symptomatic heart failure, usually in combination with diuretics and digitalis.

  • Left Ventricular Dysfunction: Prescribed for asymptomatic patients with a reduced ejection fraction ($LVEF < 35\%$) to improve survival and reduce the rate of hospitalization.

  • Diabetic Nephropathy: Frequently used off-label at low doses to protect kidney function in diabetic patients by reducing intraglomerular pressure.

  • Pediatric Hypertension: A standard dose for children where weight-based titration is required.

Mechanism of Action

Enalapril is a prodrug that is bioactivated in the liver to its active metabolite, Enalaprilat.

Enzyme Inhibition: It inhibits the ACE enzyme, which is responsible for converting Angiotensin I to Angiotensin II (a potent vasoconstrictor).

Vasodilation: By reducing Angiotensin II levels, it promotes systemic vasodilation, thereby lowering peripheral vascular resistance.

Aldosterone Reduction: It also reduces the secretion of aldosterone, leading to decreased sodium and water retention, which further lowers blood pressure and eases the workload on the heart.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Enalapril 2.5 mg is a high-precision cardiovascular product:

  • Micro-Dose Content Uniformity: Since 2.5 mg is a small amount of active ingredient per tablet, as a WHO-GMP manufacturer, we utilize validated wet granulation or direct compression with high-precision blending to ensure the API is perfectly distributed.

  • Stability for Global Trade: Enalapril Maleate is susceptible to hydrolysis and cyclization (forming a diketopiperazine impurity). We utilize Alu-Alu blister packaging or desiccants in HDPE bottles to ensure a 36-month shelf life in Zone IVb (hot/humid) climates.

  • Dossier Support: We provide comprehensive CTD/eCTD Dossiers and bioequivalence data against the innovator (Vasotec/Renitec) to support our B2B partners in international registration.

  • Market Positioning: This “low-strength” SKU is essential for hospital tenders and cardiology clinics where precise titration is a clinical requirement.

What is duloxetine 20 mg used for?

In the pharmaceutical industry, Duloxetine 20 mg is a potent Serotonin-Norepinephrine Reuptake Inhibitor (SNRI). As a pharmacist, I classify this 20 mg strength as a critical “starting dose” or “titration dose.” Because SNRIs can cause initial nausea or dizziness, the 20 mg dose allows the patient’s system to adapt before moving to the standard therapeutic maintenance dose of 40 mg or 60 mg.

Primary Clinical Uses

  • Major Depressive Disorder (MDD): Used to improve mood, sleep, and energy levels by balancing neurotransmitters in the brain.

  • Generalized Anxiety Disorder (GAD): Effective for managing chronic, excessive worry and physical symptoms of anxiety.

  • Diabetic Peripheral Neuropathic Pain: A frontline treatment for the burning, stabbing, or “pins and needles” pain caused by nerve damage in diabetic patients.

  • Fibromyalgia: Used to manage the chronic widespread muscle pain and stiffness associated with this condition.

  • Chronic Musculoskeletal Pain: Indicated for the management of chronic low back pain and osteoarthritis pain.

    Mechanism of Action: Dual-Reuptake Inhibition

Duloxetine works by inhibiting the reabsorption (reuptake) of two key chemical messengers:

Serotonin: Improving serotonin levels helps regulate mood and emotional stability.

Norepinephrine: By increasing norepinephrine levels, Duloxetine effectively modulates pain signals in the spinal cord, which explains why it is successful for physical pain conditions where standard antidepressants often fail.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Duloxetine 20 mg is a technically demanding product:

  • Acid-Labile Protection (Pellet Technology): Duloxetine is unstable in the acidic environment of the stomach. As a WHO-GMP manufacturer, we produce Duloxetine as enteric-coated pellets inside a hard gelatin capsule. This ensures the medication bypasses the stomach and is absorbed only in the small intestine.

  • Moisture Sensitivity: The pellets are highly hygroscopic. We utilize Alu-Alu blister packaging to provide a superior moisture barrier, ensuring a 24-36 month shelf life for export to Zone IVb climates (Africa, SE Asia).

  • B2B & Institutional Supply: This is a core product for neurology and psychiatry distributors. Our Mumbai facility provides full CTD/eCTD Dossiers and bioequivalence data against the innovator (Cymbalta) for international registration.

  • Dose Flexibility: While 20 mg is the starting point, we also manufacture 30 mg, 40 mg, and 60 mg to support complete patient titration cycles for our B2B partners.

Add to cart